Skip to main content
OpenTrials
Completed

NCT Number: NCT04082143

CATER: Comprehensive Alveolar and Tooth Esthetic Replacement

The purpose of this study is to prospectively evaluate whether including an allogeneic gum graft (PerioDerm*) during dental implant therapy improves implant health and appearance.

On the day of implant surgery, participating subjects will be randomized to either receive or not receive a supplemental gum graft along with the implant. Participating subjects will also be asked to complete a brief (about 15 questions) oral health questionnaire.

Participating subjects will return to the clinic about 8 weeks post surgery for digital crown impressions and again at 11-13 weeks after surgery for crown placement. Participating subjects will also return to clinic at 1 year after implant placement for implant evaluation. At this final study appointment, x-rays and a 3D intraoral scan will be obtained for the purpose of measuring alveolar volume. The health of the mucosa surrounding the implant and subject satisfaction will be assessed via bleeding upon probing and completion of a brief questionnaire, respectively.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 3

Primary location

University of Illinois at Chicago College of Dentistry

Chicago, Illinois, 60611, United States

About this study

An alveolar ridge is the part of the jawbone which immediately surrounds and anchors the tooth socket ("alveolus"). Similar to any bone or muscle atrophying when not used, the alveolar ridge will shrink ("resorb") following tooth extraction. The volume of an alveolar ridge can be measured by both 3 Dimensional ("3D") intraoral scan and radiography, and is used clinically as a metric of oral health.

A dental implant is a medical-grade titanium screw placed into healed alveolar bone or a tooth socket following tooth extraction. It replaces the tooth root and supports the crown, or "dental cap"; an artificial tooth generally made with porcelain or surgical grade metals.

Implant success requires both sufficient bone alveolar volume and sufficient mucosal tissue to protect against biofilm-mediated inflammation, assure functional comfort and contribute to dental implant esthetics. Following dental implant placement, the alveolar ridge resorbs approximately 0.5 to 1.0 mm during the first year. Healed ridges are also often volumetrically deficient, losing up to 30% of their horizontal volume following tooth extraction.

To remedy this, peri-implant mucosal grafting has been proposed and is currently part of dental implant therapy. Both autogenous grafts (mucosal connective tissue from the roof of the patient's own mouth or "palate") and allogeneic grafts (collagen-rich grafts derived from a genetically non-identical human donor) are used for these purposes, but there is controversy regarding the effectiveness of supplemental graft use during implant treatment.

The purpose of this study is to prospectively evaluate whether including an allogeneic gum graft (PerioDerm*) during dental implant therapy improves implant health and appearance.

On the day of implant surgery, participating subjects will be randomized to either receive or not receive a supplemental gum allograft along with the implant. Participating subjects will also be asked to complete a brief (about 15 questions) oral health questionnaire.

Participating subjects will return to the clinic about 8 weeks post surgery for digital crown impressions and again at 11-13 weeks after surgery for crown placement. Participating subjects will also return to clinic about 1 year after implant placement for assessment of the implant evaluation. At this final study appointment, x-rays, a 3D intraoral scan and intraoral photographs of the implant will be obtained for the purpose of measuring alveolar volume. The health of the mucosa surrounding the implant and subject satisfaction will be measured via bleeding upon probing and completion of a brief questionnaire, respectively.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • At least 18 years of age
  • Willing and able to provide informed consent
  • In need of one implant to replace a missing tooth
  • At least 20 teeth in good repair and occlusion
  • Sufficient bone volume for dental implant placement without required bone augmentation
  • Site development (soft and/or bone tissue) performed at least 5 months before implant placement, when required

Exclusion criteria

  • Current smoker
  • Implant cannot be placed without bone graft
  • Unable to pay for crown
  • Untreated rampant caries and/or uncontrolled periodontitis
  • Absence of adjacent (mesial and/or distal) natural tooth
  • Uncontrolled diabetes
  • Systemic or local disease or condition that would compromise post-operative healing and/or osseointegration
  • use of bisphosphonates
  • History of radiation in the head and neck region
  • Unable or unwilling to return for follow-up visits
  • Unrealistic esthetic or functional demands
  • Unlikely to be able to comply with study procedures
  • Unwilling or unable to provide informed consent

Treatment and study plan

Allograft mucosal enhancement with dental implant

Device

implant placement with allograft mucosal enhancement

No allograft mucosal enhancement at time of dental implant placement

Device

implant placement without allograft mucosal enhancement

Primary outcomes

  1. Percent Change in Volume of Alveolar Ridge as Measured by 3D Intraoral Scanning

    Time frame: 12 months post implant surgery

    Volume of the alveolar ridge (percentage change of the volume) as measured by 3D Intraoral scanning

Secondary outcomes

  1. Percentage of Implant Survival

    Time frame: 12 months post implant surgery

    Implant survival at 12 months post implant surgery. Percentage of implants surviving after 12 months of placement

  2. Marginal Bone Levels (MBLs)

    Time frame: 12 months post implant surgery

    Marginal bone levels (in millimeters) as measured by radiographic translucency. Bone levels between implant/abutment interface and crest of the bone were measured at time of implant placement and at 12 months later. The negative sign in the results below indicates that there was bone loss in both groups.

  3. Vertical Tissue Change as Measured by 3D Intraoral Scanning

    Time frame: 12 months post surgery

    This measurement is for the vertical position of the gingival margin change based on superimposed 3D intraoral scans

Other outcomes

  1. Patient Satisfaction

    Time frame: 12 months post implant surgery

    Patient satisfaction with implant therapy as measured by the Oral Health Impact Profile

Sponsors and collaborators

Lead sponsor

University of Illinois at Chicago

Other

Collaborators

  • Dentsply Sirona Implants and Consumables

Registry information

Acronym: CATER

Important dates

Study start
2019
Primary completion
2022
Study completion
2022
First posted
Sep 9, 2019
Registry last updated
Feb 28, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.